Tenax Therapeutics (TENX)
Develops oral levosimendan in Phase 3 trials for PH-HFpEF.
$1.92
Pre-market+0.07 (+4.07%)
At close$1.85(+2.50%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.38
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Jul '26Nov '26
Reported−$0.18−$0.28−$0.27−$0.40−$0.38−$0.35−$0.35Pending
Estimate−$0.52−$0.48−$0.50−$1.33−$1.26−$0.40−$0.38−$0.38
Surprise+65.4%+41.7%+46.0%+69.9%+69.8%+12.5%+8.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Jul '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.38 | — | — |
| Jul 2026 | −$0.38 | −$0.35 | +8.2% |
| May 2026 | −$0.40 | −$0.35 | +12.5% |
| Mar 2026 | −$1.26 | −$0.38 | +69.8% |
| Nov 2025 | −$1.33 | −$0.40 | +69.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.38 | — | — | — | — | — | — |
| Jul 31, 2026 | −$0.38 | −$0.35 | +8.2% | — | — | — | −9.3% |
| May 12, 2026 | −$0.40 | −$0.35 | +12.5% | — | — | — | −2.1% |
| Mar 10, 2026 | −$1.26 | −$0.38 | +69.8% | — | — | — | +0.8% |
| Nov 12, 2025 | −$1.33 | −$0.40 | +69.9% | — | — | — | −4.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 16, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 17, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 15, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 2, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 21, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 14, 2016 | |||||||
| Dec 10, 2015 | |||||||
| Sep 9, 2015 | |||||||